A full-body scanner that is 40 times more sensitive and 10 times faster than existing machines, is now in operation at Guy's and St Thomas'. Peter Kyle and Wes Streeting spoke to staff and patients about how the scanner is speeding up diagnoses and treatments 👇

A new national network of total-body PET scanners will support researchers to detect and treat diseases earlier. The first scanner was officially unveiled yesterday by Peter Kyle and Wes Streeting at St Thomas’ Hospital. More: orlo.uk/cg0I5

A new cutting-edge whole-body #PET scanner, unveiled at Guy's and St Thomas' in London, will speed up cancer and heart condition diagnoses. Co-managed by @Imperialcollege and King's College London, it is part of the national NPIP network. Surgery and Cancer imperial.ac.uk/news/258773/mi…

We were delighted to welcome Wes Streeting and Peter Kyle to King’s to learn about a new total-body PET scanner that could transform drug discovery and diagnose serious illnesses earlier. The scanner will provide unparalleled insights into human biology. kcl.ac.uk/news/secretari…

A full body scanner that is more sensitive & faster than current machines is now open in London. This new technology aims to support earlier diagnosis of diseases like cancer and will contribute to an imaging data bank for researchers to use to improve understanding of disease.

A new cutting-edge whole-body #PET scanner, unveiled at Guy's and St Thomas' in London, will speed up cancer and heart condition diagnoses. Co-managed by S&C's Professor Eric Aboagye and colleagues King's College London, it is part of the national NPIP network. ⬇️ imperial.ac.uk/news/258773/mi…

🔊 Exciting news from Medicines Discovery Catapult and NPIP! The first total-body #PETScanner is now operational at Guy's and St Thomas'. This cutting-edge tech is 40x more sensitive and 10x faster, accelerating diagnoses & unlocking new possibilities in #MedicalResearch 🧬🧠

Last week NPIP revealed one of the UK’s first #TotalBodyPET scanners at Guy's and St Thomas'. MDC CEO Chris Molloy was joined by Ministers, Rt Hon Peter Kyle MP, Rt Hon Wes Streeting MP and Sarah, the first patient scanned. 🔗 hubs.li/Q02-kBgL0

Turning Nuclear Waste into Breakthrough Cancer Treatments. MDC & United Kingdom National Nuclear Laboratory have received funding to drive the development of innovative approaches for new cancer treatments. Together, UKNNL & MDC will explore precision #NuclearMedicine & options for making the material available

Turning nuclear waste into more effective cancer treatment: UKNNL & Medicines Discovery Catapult secure UK Research and Innovation funding to explore groundbreaking therapy using Lead-212 from spent nuclear fuel. This could transform cancer treatment and establish the UK as a global leader in precision nuclear

Delighted to have our paper published NuclearMedicineComms sharing an important event bringing together patients, parents & professionals #neuroblastoma #molecularradiotherapy #PPIE journals.lww.com/nuclearmedicin… Great to work alongside @MarkGaze & colleagues CCLG Neuroblastoma UK 🎗 Solving Kids' Cancer UK 🎗

Next week, Dr Juliana Maynard will be presenting her talk ‘Working Strategically Across Research Councils to Ensure Collaboration at a National Level’, as part of a series of webinars by bnmsnews. 🔗 Learn more: eu1.hubs.ly/H0hg3k-0 #BNMS

We are looking forward to attending the American Association for Cancer Research® (AACR) Annual Meeting 2025, in Chicago next month. Visit us at South Building, booth 4746. Event details: 📆 27 – 30 April 📍 South Hall A, McCormick Convention Center, Chicago #AACR25 AACR

Introducing the Siemens Healthineers Healthineers Team who work as onsite Scientists at King's College London and The The University of Edinburgh in partnership with NPIP: eu1.hubs.ly/H0j5GZs0  #TotalBodyPET #PETImaging #DrugDiscovery